Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose: This retrospective study was carried out to evaluate the efficacy and toxicity of radiation therapy (RT) with/without cisplatin-based chemotherapy in nasopharyngeal cancer (NPC). Materials and Methods: One hundred forty six patients with NPC received curative RT and/or cisplatin-based chemotherapy. Thirty-nine patients were treated with induction chemotherapy (IC), including cisplatin and 5-fluorouracil followed by RT. Another 63 patients were treated with concurrent chemoradiotherapy (CCRT) using cisplatin, and 22 patients were treated with IC followed by CCRT. The remaining 22 patients were treated with RT alone. Results: One hundred four (80.0%) patients achieved complete response (CR), and 23 (17.7%) patients achieved partial response (PR). The patterns of failure were: locoregional recurrences in 21.2% and distant metastases in 17.1%. Five-year overall survival (OS) and progression free survival (PFS) were 50.7% and 45.0%, respectively. Multivariate Cox stepwise regression analysis revealed CR to chemoradiotherapy to be a powerful prognostic factor for OS. CR to chemoradiotherapy and completion of radiation according to the time schedule were favorable prognostic factors for PFS. A comparison of each treatment group (IC → RT vs. CCRT vs. IC → CCRT vs. RT alone) revealed no significant differences in the OS or PFS. However, subgroup analysis showed significant differences in both OS and DFS in favor of the combined chemoradiotherapy group compared with RT alone, for stage IV and T3-4 tumors. Grade 3-4 toxicities were more common in the combined chemoradiotherapy arm, particularly in the CCRT group. Conclusions: This study was limited in that it was a retrospective study, much time was required to collect patients, and there were imbalances in the number of patients in each treatment group. Combined chemoradiotherapy remarkably prolonged the OS and PFS in subgroup patients with stage IV or T3-4 NPC.
Abstract
Purpose: This retrospective study was carried out to evaluate the efficacy and toxicity of radiation therapy (RT) with/without cisplatin-based chemotherapy in nasopharyngeal cancer (NPC). Materials and Methods: One hundred forty six patients with NPC received curative RT and/or cisplatin-based chemotherapy. Thirty-nine patients were treated with induction chemotherapy (IC), including cisplatin and 5-fluorouracil followed by RT. Another 63 patients were treated with concurrent chemoradiotherapy (CCRT) using cisplatin, and 22 patients were treated with IC followed by CCRT. The remaining 22 patients were treated with RT alone. Results: One hundred four (80.0%) patients achieved complete response (CR), and 23 (17.7%) patients achieved partial response (PR). The patterns of failure were: locoregional recurrences in 21.2% and distant metastases in 17.1%. Five-year overall survival (OS) and progression free survival (PFS) were 50.7% and 45.0%, respectively. Multivariate Cox stepwise regression analysis revealed CR to chemoradiotherapy to be a powerful prognostic factor for OS. CR to chemoradiotherapy and completion of radiation according to the time schedule were favorable prognostic factors for PFS. A comparison of each treatment group (IC → RT vs. CCRT vs. IC → CCRT vs. RT alone) revealed no significant differences in the OS or PFS. However, subgroup analysis showed significant differences in both OS and DFS in favor of the combined chemoradiotherapy group compared with RT alone, for stage IV and T3-4 tumors. Grade 3-4 toxicities were more common in the combined chemoradiotherapy arm, particularly in the CCRT group. Conclusions: This study was limited in that it was a retrospective study, much time was required to collect patients, and there were imbalances in the number of patients in each treatment group. Combined chemoradiotherapy remarkably prolonged the OS and PFS in subgroup patients with stage IV or T3-4 NPC.
참고문헌 (25)
- Altun M., "Undifferentiated nasopharyngeal cancer (UCNT):Current diagnostic and therapeutic aspects", Int J Radiat OncolBiol Phys, 32, pp.859~77 (1995)
- Ho JH, "An epidemiologic and clinical study of nasopharyngealcarcinoma", Int J Radiat Oncol Biol Phys, 4, pp.182~89 (1978)
- Lin JC, "Phase III study of concurrent chemoradiotherapy versus radiotherapyalone for advanced nasopharyngeal carcinoma: positiveeffect on overall and progression free survival", J Clin Oncol, 21, pp.631~7 (2003)
- Teo P., "Significant prognosticators after primary radiotherapy in 903nondisseminated nasopharyngeal carcinoma evaluated by computertomography", Int J Radiat Oncol Biol Phys, 36, pp.291~304 (1996)
- Chan AT, "Concurrent chemotherapy-radiotherapy compared withradiotherapy alone in locoregionally advanced nasopharyngealcarcinoma: progression-free survival analysis of phase IIIrandomized trial", J Clin Oncol, 20, pp.2038~44 (2002)
- Ali H., "Chemotherapy in advanced nasopharyngealcancer", Oncology, 14, pp.1223~30 (2000)
- Chan AT, "A prospective randomized study of chemotherapy adjunctiveto definitive radiotherapy in advanced nasopharyngealcarcinoma", Int J Radiat Oncol Biol Phys, 33, pp.569~77 (1995)
- Rossi A., "Adjuvant chemotherapy with vincristine,cyclophosphamide, and doxorubicin after radiotherapy in localregionalnasopharyngeal cancer: Results of a 4-year multicenterrandomized study", J Clin Oncol, 6, pp.1401~10 (1988)
- "International Nasopharynx Cancer Study Group: Preliminaryresults of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs.radiotherapy alone in stage IV (≥N2, M0) undifferentiatednasopharyngeal carcinoma: A positive effect on progressionfreesurvival. Int J Radiat Oncol Biol Phys. 1996;35:463-9", ~ (1996)
- Chua DT, "Preliminary report of the Asian-OceanianClinical Oncology Association randomized trial comparingcisplatin and epirubicin followed by radiotherapy versusradiotherapy alone in the treatment of patients with locoregionallyadvanced nasopharyngeal carcinoma", Cancer, 83, pp.2270~83 (1998)
- Huncharek M., "Combined chemoradiation versusradiation therapy alone in locally advanced nasopharyngealcarcinoma: results of a meta-analysis of 1,528 patients fromsix randomized trials", Am J Clin Oncol, 25, pp.219~23 (2002)
- Baujat B., "Chemotherapy in locally advanced nasopharyngeal carcinoma:An individual patient data meta-analysis of eight randomizedtrials and 1,753 patients", Int J Radiat Oncol Biol Phys, 64, pp.47~56 (2006)
- Boussen H., "Chemotherapy of metastatic and", or recurrentundifferentiated nasopharyngeal carcinoma with cisplatin,bleomycin, and fluorouracil, 1991, pp.9, 1675~81
- Al-Sarraf M., "Chemoradiotherapy versus radiotherapy in patientswith advanced nasopharyngeal cancer: Phase III randomizedIntergroup Study 0099", J Clin Oncol, 16, pp.1310~7 (1998)
- Ma J., "Results of a prospective randomized trial comparing neoadjuvantchemotherapy plus radiotherapy with radiotherapyalone in patients with locoregionally advanced nasopharyngealcarcinoma", J Clin Oncol, 19, pp.1350~7 (2001)
- Tan EH, "Concurrent chemoradiotherapy followed by adjuvant chemotherapyin Asian patients with nasopharyngeal carcinoma: toxicitiesand preliminary results", Int J Radiat Oncol Biol Phys, 45, pp.597~601 (1999)
- Lee AW, "Preliminary results of a randomized study on therapeuticgain by concurrent chemotherapy for regionally advancednasopharyngeal carcinoma: NPC-9901 trial by the Hong Kongnasopharyngeal carcinoma study group", J Clin Oncol, 23, pp.6966~75 (2005)
- Wee J., "Randomized trial of radiotherapy versus concurrent chemoradiotherapyfollowed by adjuvant chemotherapy in patientswith AJCC", IUAC stage III and IV nasopharyngeal cancer ofthe endemic varieties, 2005, pp.23, 6730~8
- Bachaud JM, "Combined postoperative radiotherapyand weekly cisplatin infusion for locally advanced head andneck carcinoma: Final report of a randomized trial", Int J RadiatOncol Biol Phys, 36, pp.999~1004 (1996)
- 김태희, "Treatment Outcome of Cisplatin-based Concurrent Chemoradiotherapy in the Patients with Locally Advanced Nasopharyngeal Cancer", Cancer Research and Treatment, 40(2), pp.62~70 (2008), 대한암학회
- Hsu MM, "Nasopharyngeal carcinoma in Taiwan:Clinical manifestations and results of therapy", Cancer, 52, pp.362~8 (1983)
- Lee AW, "Retrospective analysis of 5037 patients with nasopharyngealcarcinoma treated during 1976-1985: Overall survivaland patterns of failure", Int J Radiat Oncol Biol Phys, 23, pp.261~70 (1992)
- Vikram B., "Patterns offailure in carcinoma of the nasopharynx: Failure at the primarysite", Int J Radiat Oncol Biol Phys, 11, pp.1455~9 (1985)
- Kwong D., "The effect of loco-regional controlon distant metastatic dissemination in the carcinoma of thenasopharynx: An analysis of 1301 patients", Int J Radiat OncolBiol Phys, 30, pp.1029~36 (1994)
- "InternationalFederation of Head and Neck Oncologic Society", 2006, ~